{
    "title": "109_hr3423",
    "content": "The Act may be cited as the \"Medical Device User Fee Stabilization Act of 2005\" and includes amendments to the Federal Food, Drug, and Cosmetic Act. The Federal Food, Drug, and Cosmetic Act is amended to adjust device user fees, including changes to subsections (b) and (c) related to fee setting and publication in the Federal Register. The Federal Food, Drug, and Cosmetic Act is amended to adjust device user fees, including changes to fee amounts for fiscal years 2006 and 2007, and allowing the Secretary to use unobligated carryover balances from previous years to ensure sufficient fee revenues. The Secretary must maintain unobligated carryover balances for operating reserves in fiscal year 2008. Notice must be provided to Congress before funds are used. The definition of 'small business' is an entity with $30,000,000 or less in gross receipts or sales. The definition of 'small business' is an entity with $30,000,000 or less in gross receipts or sales, which is now proposed to be increased to $100,000,000 in the most recent Federal income tax return. The Secretary must meet performance goals for fiscal year 2005 if the appropriated amount is equal to or greater than $205,720,000 multiplied by the adjustment factor. If the appropriated amount is more than 1 percent less than the required amount, specific conditions apply. The text chunk involves amending certain provisions related to performance goals for fiscal year 2005, including changes to the time period and percentage requirements. The text chunk involves amending provisions related to performance goals for fiscal year 2005, including changes to time period and percentage requirements. Amendments include replacing \"sum\" with \"amount,\" adjusting subparagraphs, and updating fiscal year funding for 2006 and 2007. Additionally, references to subsection (c)(5) are changed to subsection (c)(1). Annual reporting requirements under the Medical Device User Fee and Modernization Act of 2002 are also modified. The text chunk involves amending reporting requirements for fiscal years 2006 and 2007 under subsection (a)(2) of the Medical Device User Fee and Modernization Act of 2002. It includes information on different types of applications, fees paid by businesses in various revenue categories, and a certification by the Secretary regarding FDA expenses for device-related functions. The text chunk discusses amending reporting requirements for fiscal years 2006 and 2007 under the Medical Device User Fee and Modernization Act of 2002. It includes details on reprocessed single-use devices and the requirements for labeling with manufacturer information. The text discusses requirements for labeling reprocessed medical devices with manufacturer information, including the use of detachable labels on packaging if the original device does not bear the manufacturer's name prominently. Guidance will be issued by the Secretary of Health and Human Services within 180 days to identify when manufacturer information is not considered prominent. The text addresses the need for prominent manufacturer information on reprocessed medical devices, with guidelines for labeling and the effective date of the regulations. The Medical Device User Fee Stabilization Act of 2005 requires manufacturer information on reprocessed medical devices, with specific guidelines for labeling and effective dates for compliance. The curr_chunk is about the roles of the Speaker of the House of Representatives and the Vice President of the United States as President of the Senate."
}